NSE · AI Signal & Stock Analysis · Bearish
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for ALIVUS is Bearish ↓ (mild move); technical trend down-trend; trading at ₹1,092.80 (-0.91% today); neutral (RSI 41).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Mild move |
|---|---|
| Technical trend | Down-trend (since 2026-07-22) |
| Price | ₹1,092.80 |
| Change today | -0.91% |
| RSI (14) | 41.00 |
| Relative volume | 0.11 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹17,025 Cr |
| P/E | 28.26 |
| Cap category | Mid Cap |
| 52-week high | -6.5% away |
| 52-week low | +27.1% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for ALIVUS (Alivus Life Sciences Limited) is Bearish with a mild move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
ALIVUS's RSI is neutral (RSI 41). A reading above 70 is typically overbought and below 30 oversold.
ALIVUS is trading about 6% below its 52-week high and 27% above its 52-week low as of Aug 14 2026, 6:50 PM.
ALIVUS's market capitalisation is ₹17,025 Cr as of Aug 14 2026, 6:50 PM.
ALIVUS is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.